A Cross-sectional Survey Assessing Carriage of Streptococcus pneumoniae in a Healthy Population in Xinjiang Uygur Autonomous Region of China

被引:4
作者
Xie Na [1 ,2 ,3 ]
Chen Zhao Yun [4 ]
Chen Tao [3 ]
Zhu Bing Qing [2 ]
Xu Li [2 ]
Gao Yuan [2 ]
Zhang Ai Yu [2 ]
Zhao Pan [2 ]
Liu Ji Wen [1 ]
Shao Zhu Jun [2 ,5 ]
机构
[1] Xinjiang Med Univ, Dept Publ Hlth, Urumqi 830054, Xinjiang, Peoples R China
[2] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China
[3] Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi 830011, Xinjiang, Peoples R China
[4] Xinjiang Med Univ, Affiliated Hosp 1, Med Lab Ctr, Urumqi 830054, Xinjiang, Peoples R China
[5] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Cross-sectional survey; Streptococcus pneumoniae carriage; Real-time PCR; Xinjiang; China;
D O I
10.3967/bes2018.029
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The carriage rate and serotype distribution of Streptococcus pneumoniae (S. pneumoniae) in a healthy population in China remains unclear. In this study, we collected the oropharyngeal swabs from 513 individuals in Xinjiang, China. Real-time PCR targeting the lytA gene and 12 serotypes were assessed to identify S. pneumoniae carriage. The total carriage rate of S. pneumoniae was 70.4% (361/513). The most prevalent serotypes were 19B/F, 18B/C, 5, and 6A/B. The highest carriage rate of S. pneumoniae was noted in children aged 6-10 years (88.6%), which merits further attention. The co-colonization rate of two or more S. pneumoniae serotypes was 79.8% (264/331). This study aimed to investigate the baseline pneumococcal carriage rate among healthy individuals in China to improve our understanding of the epidemiology of S. pneumoniae.
引用
收藏
页码:233 / +
页数:6
相关论文
共 9 条
[1]   Carriage of Streptococcus pneumoniae and Other Respiratory Bacterial Pathogens in Low and Lower-Middle Income Countries: A Systematic Review and Meta-Analysis [J].
Adegbola, Richard A. ;
DeAntonio, Rodrigo ;
Hill, Philip C. ;
Roca, Anna ;
Usuf, Effua ;
Hoet, Bernard ;
Greenwood, Brian M. .
PLOS ONE, 2014, 9 (08)
[2]  
[Anonymous], 2012, Wkly Epidemiol Rec, V87, P129
[3]   Realtime PCR Is More Sensitive than Multiplex PCR for Diagnosis and Serotyping in Children with Culture Negative Pneumococcal Invasive Disease [J].
Azzari, Chiara ;
Moriondo, Maria ;
Indolfi, Giuseppe ;
Cortimiglia, Martina ;
Canessa, Clementina ;
Becciolini, Laura ;
Lippi, Francesca ;
de Martino, Maurizio ;
Resti, Massimo .
PLOS ONE, 2010, 5 (02)
[4]   Streptococcus pneumoniae colonisation:: the key to pneumococcal disease [J].
Bogaert, D ;
de Groot, R ;
Hermans, PWM .
LANCET INFECTIOUS DISEASES, 2004, 4 (03) :144-154
[5]   The rise and fall of pneumococcal serotypes carried in the PCV era [J].
Devine, Vanessa T. ;
Cleary, David W. ;
Jefferies, Johanna M. C. ;
Anderson, Rebecca ;
Morris, Denise E. ;
Tuck, Andrew C. ;
Gladstone, Rebecca A. ;
O'Doherty, Grace ;
Kuruparan, Priyasharmila ;
Bentley, Stephen D. ;
Faust, Saul N. ;
Clarke, Stuart C. .
VACCINE, 2017, 35 (09) :1293-1298
[6]   Assessing the diagnostic accuracy of PCR-based detection of Streptococcus pneumoniae from nasopharyngeal swabs collected for viral studies in Canadian adults hospitalised with community-acquired pneumonia: a Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research (CIRN) study [J].
Gillis, Hayley D. ;
Lang, Amanda L. S. ;
ElSherif, May ;
Martin, Irene ;
Hatchette, Todd F. ;
McNeil, Shelly A. ;
LeBlanc, Jason J. .
BMJ OPEN, 2017, 7 (06)
[7]  
Johargy AK, 2017, J MICROBIAL BIOCH TE, V8, P14
[8]   Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine [J].
Pilishvili, Tamara ;
Lexau, Catherine ;
Farley, Monica M. ;
Hadler, James ;
Harrison, Lee H. ;
Bennett, Nancy M. ;
Reingold, Arthur ;
Thomas, Ann ;
Schaffner, William ;
Craig, Allen S. ;
Smith, Philip J. ;
Beall, Bernard W. ;
Whitney, Cynthia G. ;
Moore, Matthew R. .
JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (01) :32-41
[9]  
Rose M, 2009, EXPERT REV VACCINES, V8, P1351, DOI [10.1586/erv.09.78, 10.1586/ERV.09.78]